Valeant Pharma

Showing 2 posts of 2 posts found.

stocks1

Weekly Movers: Valeant, Anacor, Regeneron…

May 23, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Acorda, Aduro Biotech, Anacor Pharma, Financial, MacroGenics, Merck, Regeneron Pharma, Valeant Pharma

The earnings season came to a close with Germany’s Merck doubling its first-quarter profits. For the week, drug trials, analyst …

valeant_logo

Valeant cuts 2016 sales, earnings outlook; shares plunge over 47%

March 15, 2016
Business Services, Manufacturing and Production, Sales and Marketing Valeant Pharma, fourth quarter, full year, results

Valeant Pharmaceuticals Inc (NYSE: VRX) cut its outlook for the first-quarter of 2016 and posted a loss for the final …

The Gateway to Local Adoption Series

Latest content